Law360, New York (November 29, 2006) -- The trial began Tuesday in the longstanding patent fight between Pfizer Inc. and generic drug maker Mylan Pharmaceuticals Inc. over Pfizer’s blockbuster drug Norvasc.
U.S. District Judge Terrence McVerry is presiding over the trial, which is expected to last over a week....


